Abstract: A cutting device for manufacturing lead tabs of a secondary battery disclosed herein cuts a band-shaped metal lead strip which is continuously supplied. The cutting device for manufacturing lead tabs of a secondary battery includes: a stud part; a punch having a blade tip integrated with the lower portion of the stud part; and a die having an upper surface, which is supplied with the metal lead strip, and a pocket, which the blade tip enters and exits when cutting the metal lead strip supplied to the upper surface. The punch and the die cut the metal lead strip to form metal terminals, and at the same time, cut the edges on both sides of the cut surface so that the edges have a smooth curvature.

Abstract: The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer).

Abstract: The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer).

Abstract: The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer).

Abstract: The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer).

Abstract: The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer).

Abstract: Disclosed herein are structure and method for connecting a fabric sensor and a digital yarn. The structure includes a sheet-type member which is configured to be worn on a body of a wearer, a first fabric sensor which is provided on the sheet-type member and senses a biological signal, a digital yarn which is provided on the first fabric sensor and has a peeled portion that is electrically connected to the first fabric sensor, a sewing yarn which couples a portion of the digital yarn to the first fabric sensor by sewing, and a second fabric sensor which is coupled to the first fabric sensor and covers an upper portion of the peeled portion.

Abstract: A data communication cable for automatically recognizing a power-supply source is disclosed. The cable includes a USB (Universal Serial Bus) port and a data port to perform a data communication between a terminal and a personal computer (PC) and provides the terminal with a charge current, so that a power-supply source is automatically recognized and adjusted to stably perform a charge operation while minimizing the number of overload occurrences and the number of faulty charging operations.

Abstract: The present invention relates to a method for expressing each of peptide antibiotics P5 3 and Anal3 35 having amphiphilicity and showing antibacterial, antifungal and anticancer activities 61, 63, 65, 67, 69, 71, on the microbial surface, using a vector containing outer membrane protein genes (pgsBCA) that are derived from Bacillus sp. strains and involved in the synthesis of poly-gamma-glutamate. Moreover, the present invention relates to lactic acid-forming bacteria having each of the peptide antibiotics P5 15 and Anal3 43 expressed on their surface, and the use thereof. According to the present invention, the peptide antibiotics can be expressed on the surface of various microorganisms transformed with the surface expression vectors. The inventive method for the surface expression of the peptide antibiotics allows the peptide antibiotics to be mass-produced without a purification process. Thus, the inventive method has very high industrial applicability.

Abstract: The present invention relates to a bone graft material and a scaffold for tissue engineering applications, which have an osteogenesis-promoting peptide immobilized on the surface. More particularly, the invention relates to a bone graft material and a scaffold for tissue engineering applications, which have a cell adhesion-inducing peptide and/or tissue growth factor-derived peptide immobilized on the surface. By the osteogenesis-promoting peptide immobilized on the surface, the inventive bone graft material and scaffold for tissue engineering applications can promote the transition, proliferation and differentiation of cells associated with regeneration, and eventually maximize the regeneration of tissue. Moreover, the peptide immobilized on the surface has low molecular weight, indicating a reduced risk of immune responses upon its application in the body, and can be present in a stable form within the body, thus showing lasting effects.

Abstract: Compositions for transport across a biological membrane include a membrane-translocating LMWP peptide and a cargo molecule. Methods for transporting a cargo molecule across a biological membrane are also described.

Abstract: An epoxy resin composition, and a method of making the same, includes an epoxy resin and a curing agent, the epoxy resin composition also includes inorganic fillers, curing accelerators, and modified silicone oils. The epoxy resin is a modified epoxy resin prepared by glycidyl etherification of a mixture of a novolac type phenolic compound having a biphenyl derivative in the molecule and a 4,4?-dihydroxy biphenyl compound, and the curing agent is a mixture of a polyaromatic curing agent and a polyfunctional curing agent.

Abstract: A data communication cable for automatically recognizing a power-supply source is disclosed. The cable includes a USB (Universal Serial Bus) port and a data port to perform a data communication between a terminal and a personal computer (PC) and provides the terminal with a charge current, so that a power-supply source is automatically recognized and adjusted to stably perform a charge operation while minimizing the number of overload occurrences and the number of faulty charging operations.

Abstract: A multi-functional child care storage for storing and treating infant care products includes a plurality of functional compartments provided in a main body and having individual spaces divided by a partition member. The functional compartments includes a refrigerating compartment for storing the infant care products at a reduced temperature, a refrigerating and heating compartment for storing, cooling and heating the infant care products, a warming-in-water compartment for warming up the infant care products and a sterilizing compartment for sterilizing the sterilizing and drying. A control unit controls the functional compartments so that each of the functional compartments is maintained at a predetermined temperature.

Abstract: A child care storage for storing an infant food and/or product includes a plurality of functional compartments for refrigerating, heating and/or sterilizing the infant food and/or product in a main body, wherein the plurality of the functional compartments include a refrigerating compartment and a sterilizing compartment; and a control unit for controlling the plurality of the functional compartments. The plurality of the functional compartments includes a refrigerating compartment. The refrigerating compartment, partitioned by partitions in the main body, includes a refrigerating space capable of being opened and closed by a first door and refrigerates the refrigerating space by a thermoelectric element.

Abstract: A multi-functional child care storage includes a plurality of functional parts partitioned by partitions. The plurality of the functional parts include a refrigerating/heating compartment for keeping therein an infant product and/or a child care product at a proper temperature; and a sterilizing/drying compartment for sterilizing, drying and keeping the infant product and/or the child care product hygienically. The refrigerating/ heating compartment includes a thermoelectric element; a heat absorbing/radiating plate connected to the thermoelectric element, for selectively absorbing or radiating heat; and a temperature sensor for detecting an indoor temperature. The sterilizing/drying compartment includes an ultraviolet germicidal lamp for irradiating ultraviolet rays into an inner space of the sterilizing/drying compartment; and a heat radiation device for discharging hot air to dry the inner space of the sterilizing/drying compartment.

Abstract: Provided are a multi-wavelength optical transceiver module and a multiplexer/demultiplexer using a thin film filter. The multi-wavelength optical transceiver module includes: a PLC platform, on which a predetermined optical waveguide unit is formed and an optical transmitter is mounted; an optical fiber coupled to one side of the PLC platform to transmit a predetermined light; a plurality of thin film filters coupled to another side of the PLC platform to separate input optical wavelengths; and an optical receiver coupled to one side of the thin film filters to receive light that is input from the optical fiber and transmits the thin film filters, thereby enabling mass production of the optical transceiver module with low cost.

Abstract: A flat cathode ray tube comprising a panel having a substantially-flat outer surface and an inner surface having a certain curvature, a funnel coupled to a rear end of the panel to form a hollow vacuum body, an electron gun fitted in a neck portion of the funnel to emit electron beams, and a shadow mask arranged at the inner surface of the panel in a state of being spaced apart by a certain distance from the inner surface of the panel, and formed with a plurality of electron beam slots, wherein the shadow mask has a curvature satisfying, at an optional point on the shadow mask, the condition “Rh?Rv”, where “Rh” represents a shorter-axis radius of the curvature, and “Rv” represents a longer-axis radius of the curvature. Using this structure, it is possible to prevent a degradation in the structural strength of the shadow mask.

Abstract: The present invention relates to a method for expressing each of peptide antibiotics P5 3 and Anal3 35 having amphiphilicity and showing antibacterial, antifungal and anticancer activities 61, 63, 65, 67, 69, 71, on the microbial surface, using a vector containing outer membrane protein genes (pgsBCA) that are derived from Bacillus sp. strains and involved in the synthesis of poly-gamma-glutamate. Moreover, the present invention relates to lactic acid-forming bacteria having each of the peptide antibiotics P5 15 and Anal3 43 expressed on their surface, and the use thereof. According to the present invention, the peptide antibiotics can be expressed on the surface of various microorganisms transformed with the surface expression vectors. The inventive method for the surface expression of the peptide antibiotics allows the peptide antibiotics to be mass-produced without a purification process. Thus, the inventive method has very high industrial applicability.

Abstract: The present invention relates to multicomponent compositions and methods of administering these compositions, which specifically translocate therapeutic molecules (e.g., drugs or prodrugs) across biological membranes thus reducing potential toxic side effects on nontargeted cells and tissues.